ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership771,587 shares
Latest Disclosed Value $ 59,335,040
State Street Corp reports 6.10% increase in ownership of ANIP / ANI Pharmaceuticals, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 771,587 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $59,335,040 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 727,204 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 6.10% during the quarter. The current value of the position is $61,109,690 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 771,587 44,383 6.10 59,335 3.36 0.0020
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 727,204 15,496 2.18 57,405 -11.94 0.0019
2025-11-14 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 711,708 -4,409 -0.62 65,192 39.52 0.0023
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 716,117 1,547 0.22 46,727 -2.33 0.0018
2025-05-15 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 714,570 -22,718 -3.08 47,840 17.38 0.0020
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 737,288 33,445 4.75 40,757 -2.94 0.0016
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 703,843 58,698 9.10 41,991 2.21 0.0017
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 645,145 70,307 12.23 41,083 3.38 0.0018
2024-05-15 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 574,838 -17,585 -2.97 39,739 21.65 0.0018
2024-02-14 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 592,423 36,940 6.65 32,666 1.29 0.0016
2023-11-14 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 555,483 69,077 14.20 32,251 23.18 0.0018
2023-08-14 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 486,406 26,234 5.70 26,183 43.25 0.0014
2023-05-15 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 460,172 12,185 2.72 18,278 1.42 0.0010
2023-05-15 2022-12-31 13F/A-99 ANI PHARMACEUTICALS COM 00182C103 447,987 -5,493 -1.21 18,023 23.65 0.0011
2023-05-15 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 447,987 -5,493 18,023 0.0011
2022-11-15 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 453,480 -12,244 -2.63 14,575 5.48 0.0009
2022-08-15 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 465,724 38,142 8.92 13,818 14.97 0.0008
2022-05-16 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 427,582 -9,998 -2.28 12,019 -40.39 0.0006
2022-02-14 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 437,580 26,560 6.46 20,164 49.47 0.0010
2021-11-15 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 411,020 10,985 2.75 13,490 -3.79 0.0007
2021-08-16 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 400,035 5,043 1.28 14,021 -1.78 0.0007
2021-07-09 2021-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 394,992 80,083 25.43 14,275 56.10 0.0008
2021-05-17 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 394,992 80,083 14,275 0.0008
2021-02-16 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 314,909 12,572 4.16 9,145 7.22 0.0006
2020-11-10 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 302,337 -2,935 -0.96 8,529 -13.60 0.0006
2020-08-14 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 305,272 -20,081 -6.17 9,872 -25.52 0.0007
2020-06-19 2020-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 325,353 15,490 5.00 13,255 -30.63 0.0012
2020-05-11 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 325,353 15,490 13,255 1,164.0559
2020-02-06 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 309,863 7,029 2.32 19,109 -13.42 0.0013
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 302,834 14,069 4.87 22,071 -7.01 0.0016
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 288,765 23,653 8.92 23,736 26.92 0.0018
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 265,112 23,714 9.82 18,701 72.07 0.0015
2019-02-12 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 241,398 -29,076 -10.75 10,868 -28.96 0.0010
2018-11-09 2018-09-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 270,474 -6,002 -2.17 15,298 -17.14 0.0012
2018-08-14 2018-06-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 276,476 -6,178 -2.19 18,463 12.18 0.0015
2018-05-15 2018-03-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 282,654 -1,586 -0.56 16,459 -10.16 0.0014
2018-02-14 2017-12-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 284,240 12,647 4.66 18,320 28.55 0.0015
2017-11-14 2017-09-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 271,593 -24,358 -8.23 14,251 2.90 0.0012
2017-08-14 2017-06-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 295,951 -8,044 -2.65 13,849 -7.96 0.0012
2017-05-15 2017-03-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 303,995 -9,482 -3.02 15,046 -20.81 0.0013
2017-02-09 2016-12-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 313,477 -25,466 -7.51 19,000 -15.52 0.0018
2017-01-13 2016-09-30 13F/A-1 ANI PHARMACEUTICALS Common equity shares 00182C103 338,943 47,504 16.30 22,491 38.22 0.0023
2016-11-14 2016-09-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 338,943 22,491
2016-08-12 2016-06-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 291,439 112,076 62.49 16,272 169.58 0.0017
2016-05-20 2016-03-31 13F/A-1 ANI PHARMACEUTICALS Common equity shares 00182C103 179,363 -208,195 -53.72 6,036 -65.49 0.0007
2016-05-12 2016-03-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 179,363 6,036
2016-02-16 2015-12-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 387,558 -247,465 -38.97 17,492 -30.30 0.0019
2015-11-16 2015-09-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 635,023 -73,464 -10.37 25,095 -42.92 0.0029
2015-08-13 2015-06-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 708,487 -10,759 -1.50 43,961 -2.30 0.0047
2015-05-15 2015-03-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 719,246 303,152 72.86 44,995 91.75 0.0046
2015-02-11 2014-12-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 416,094 338,278 434.72 23,465 967.08 0.0023
2014-11-12 2014-09-30 13F/A-1 ANI PHARMACEUTICALS Common equity shares 00182C103 77,816 5,940 8.26 2,199 -11.22 0.0002
2014-11-10 2014-09-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 77,816 2,199
2014-08-12 2014-06-30 13F ANI PHARMACEUTICALS Common equity shares 00182C103 71,876 58,813 450.23 2,477 15,381.25 0.0003
2014-02-06 2013-12-31 13F ANI PHARMACEUTICALS Common equity shares 00182C103 13,063 25 0.19 16 23.08 0.0000
2013-08-08 2013-06-30 13F BIOSANTE PHARMACEUTICALS Common equity shares 00182C103 13,038 13,038 13 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.